Expect domestic air passenger traffic to return pre-COVID level by 2022-23, says ICRAExpecting domestic air passenger traffic to return to the pre-COVID-19 level by the financial year 2022-23 and international by 2023-24, rating agency ICRA on Monday said there could be a delay in the commercialisation of expanded capacity by 9-12 months. ICRA also said the cargo volumes are likely to grow around 36 per cent in 2021-22 and six per cent in 2022-23 after a 25 per cent contraction this fiscal, ...

\"People are dying in poor countries,\" Ngozi Okonjo-Iweala, new chief of WTO, said on her first day in office

On Monday, the prime minister took his first dose of the COVID-19 vaccine at AIIMS, Delhi. The PM was administered Bharat Biotech's COVAXIN by Sister P Niveda from Puducherry

Just the two shots have been used in what India calls the world's biggest immunisation programme to cover 300 million people by August, starting with healthcare and other workers to reach the elderly and those with existing conditions by March

Coronavirus vaccine: Pfizer was the first pharmaceutical company to seek EUA from Drugs Controller General of India (DCGI) after its vaccine was approved in the UK and Bahrain

India boasts one of the biggest pharmaceutical industries globally and several countries have already approached it for procuring COVID-19 vaccines

The Union Health Ministry has claimed that India has become the fastest country in the world to reach the 4 million vaccination mark in 18 days

Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines

Budget 2021: In order to replenish its coffers, the government is likely to announce a coronavirus cess. Preliminary talks on revenue increasing measures have been held

Serum in its reply stated that both the companies operate in different product categories and there is no scope for confusion over the trademark

Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months

India bans TikTok permanently; app evaluates notice Following the temporary app ban dated June 29, 2020, the government of India has issued a notice to TikTok on the permanent ban of the app in the country. Along with TikTok, the government has issued a similar permeant ban notice to 177 Chinese apps which were banned earlier, says sources. Conversely, one of the banned Chinese app has been unblocked. WEF 2021: Jinping calls for global cooperation, says strong should not bully the weak ...

India's Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company's application was made in early December

Tata Steel, ArcelorMittal Nippon Steel India and Rashtriya Ispat Nigam Ltd said they will continue to support the government in the nationwide drive and will wait till vaccines are available for corporates

Company shall be liable for all adversities as per CDSCO/Drugs and Cosmetics Act/DCGI policy/approval, says government's purchase order with vaccine makers

Centre has placed orders in advanced commitments for over 6 crore doses of COVID vaccine from SII and Bharat Biotech for inoculating 3 crore healthcare and frontline workers in first vaccination phase that starts January 16

The first order of 1.1 crore doses will be worth Rs 231 crore, while the total amount, including the commitment for 4.5 crore doses, with the total estimated to reach Rs 1,176 crore at current rates

Three temperature-controlled trucks rolled out of Serum Institute's gates before 5 am, on their way to Pune airport, from where the vaccines will be transported across the country on a special cargo plane

COVID-19 vaccines for 3 crore healthcare and frontline workers, which are to be administered in the beginning of the vaccination drive, will be paid by the central government

The government has placed an order for Oxford-AstraZeneca's vaccine against COVID-19 manufactured by Serum Institute of India